Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BKGM
|
Francisco M. Atalig
SVP/Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 192 Added 13.56% |
$1,611
$8.39 p/Share
|
Mar 31
2014 |
|
FDX
|
William J Logue
President/CEO - FedEx Freight |
BUY
Exercise of conversion of derivative security
|
Direct | 1,372 Added 4.35% |
$99,936
$72.84 p/Share
|
Mar 31
2014 |
|
FDX
|
John L Merino
CVP PRIN ACCT OFFICER |
SELL
Open market or private sale
|
Direct | 18,210 Reduced 44.49% |
$2,406,634
$132.16 p/Share
|
Mar 31
2014 |
|
FDX
|
John L Merino
CVP PRIN ACCT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 18,210 Added 30.79% |
$1,519,989
$83.47 p/Share
|
Mar 31
2014 |
|
URI
|
Bobby J Griffin |
BUY
Grant, award, or other acquisition
|
Direct | 299 Added 1.07% |
$28,387
$94.94 p/Share
|
Mar 31
2014 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,456 Reduced 9.36% |
$259,200
$75.0 p/Share
|
Mar 31
2014 |
|
UPS
|
Michael L Eskew
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 628 Reduced 0.33% |
$61,130
$97.34 p/Share
|
Mar 28
2014 |
|
UPS
|
Michael L Eskew
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,347 Added 2.7% |
$520,477
$97.34 p/Share
|
Mar 28
2014 |
|
AYI
|
Mark A Black
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 16,000 Added 29.48% |
-
|
Mar 28
2014 |
|
JEF
|
Richard B Handler
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 13,983 Added 0.12% |
$381,456
$27.28 p/Share
|
Mar 28
2014 |
|
JEF
|
Brian P Friedman
President |
BUY
Grant, award, or other acquisition
|
Direct | 1,409 Added 0.03% |
$38,438
$27.28 p/Share
|
Mar 28
2014 |
|
JEF
|
Michael J. Sharp
EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 42 Added 0.23% |
$1,146
$27.28 p/Share
|
Mar 28
2014 |
|
JEF
|
W Patrick Campbell |
BUY
Grant, award, or other acquisition
|
Direct | 81 Added 0.09% |
$2,210
$27.28 p/Share
|
Mar 28
2014 |
|
JEF
|
Robert Eugene Joyal |
BUY
Grant, award, or other acquisition
|
Direct | 63 Added 0.14% |
$1,719
$27.28 p/Share
|
Mar 28
2014 |
|
JEF
|
Michael T O Kane |
BUY
Grant, award, or other acquisition
|
Direct | 64 Added 0.2% |
$1,746
$27.28 p/Share
|
Mar 28
2014 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,411 Reduced 29.45% |
$1,143,188
$74.18 p/Share
|
Mar 28
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,468,459
$307.77 p/Share
|
Mar 28
2014 |
|
HOFD
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Direct | 6,986,337 Added 42.48% |
-
|
Mar 28
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.12% |
$95,300,287
$310.48 p/Share
|
Mar 27
2014 |
|
AAPL
|
Daniel J. Riccio
Senior Vice President |
SELL
Open market or private sale
|
Direct | 3,064 Reduced 100.0% |
$1,648,800
$538.12 p/Share
|
Mar 27
2014 |
|
HD
|
Teresa Wynn Roseborough
EVP, Gen. Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct | 6,128 Added 21.89% |
-
|
Mar 26
2014 |
|
HD
|
Francis S Blake
Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 30,112 Added 3.84% |
-
|
Mar 26
2014 |
|
HD
|
Francis S Blake
Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 16,351 Reduced 2.21% |
$1,289,603
$78.87 p/Share
|
Mar 26
2014 |
|
IDCC
|
Allen A Proithis
EVP, Solutions Group |
SELL
Sale (or disposition) back to the issuer
|
Direct | 0 Reduced 0.0% |
$0
$33.08 p/Share
|
Mar 26
2014 |
|
IDCC
|
Allen A Proithis
EVP, Solutions Group |
SELL
Payment of exercise price or tax liability
|
Direct | 333 Reduced 2.12% |
$11,016
$33.08 p/Share
|
Mar 26
2014 |
|
NEM
|
Chris J Robison
EVP, COO |
BUY
Open market or private purchase
|
Direct | 4,494 Added 15.5% |
$105,924
$23.57 p/Share
|
Mar 26
2014 |
|
HD
|
Matt Carey
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 9,086 Added 11.28% |
-
|
Mar 26
2014 |
|
HD
|
Timothy M Crow
EVP - Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 8,347 Added 4.02% |
-
|
Mar 26
2014 |
|
HD
|
Marvin R Ellison
EVP - U.S. Stores |
BUY
Grant, award, or other acquisition
|
Direct | 11,833 Added 5.94% |
-
|
Mar 26
2014 |
|
HD
|
Mark Holifield
EVP-Supply Chain & Product Dev |
BUY
Grant, award, or other acquisition
|
Direct | 8,452 Added 13.98% |
-
|
Mar 26
2014 |
|
HD
|
Craig A Menear
Chair |
BUY
Grant, award, or other acquisition
|
Direct | 14,580 Added 11.26% |
-
|
Mar 26
2014 |
|
HD
|
Carol B Tome
CFO & EVP - Corp. Services |
BUY
Grant, award, or other acquisition
|
Direct | 14,580 Added 2.37% |
-
|
Mar 26
2014 |
|
ALNY
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 344,448 Added 3.64% |
$23,036,681
$66.88 p/Share
|
Mar 25
2014 |
|
HD
|
Matt Carey
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 5,767 Reduced 8.46% |
$458,303
$79.47 p/Share
|
Mar 25
2014 |
|
HD
|
Timothy M Crow
EVP - Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct | 6,180 Reduced 3.14% |
$491,125
$79.47 p/Share
|
Mar 25
2014 |
|
HD
|
Marvin R Ellison
EVP - U.S. Stores |
SELL
Payment of exercise price or tax liability
|
Direct | 7,827 Reduced 4.27% |
$622,012
$79.47 p/Share
|
Mar 25
2014 |
|
HD
|
Mark Holifield
EVP-Supply Chain & Product Dev |
SELL
Payment of exercise price or tax liability
|
Direct | 5,562 Reduced 11.32% |
$442,012
$79.47 p/Share
|
Mar 25
2014 |
|
HD
|
Craig A Menear
Chair |
SELL
Payment of exercise price or tax liability
|
Direct | 7,827 Reduced 7.24% |
$622,012
$79.47 p/Share
|
Mar 25
2014 |
|
HD
|
Carol B Tome
CFO & EVP - Corp. Services |
SELL
Payment of exercise price or tax liability
|
Direct | 11,947 Reduced 1.99% |
$949,428
$79.47 p/Share
|
Mar 25
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Bona fide gift
|
Direct | 2,445 Reduced 1.0% |
-
|
Mar 25
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 2,445 Reduced 2.16% |
$45,232
$18.5 p/Share
|
Mar 25
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 2,445 Added 0.99% |
$24,450
$10.0 p/Share
|
Mar 25
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
BUY
Bona fide gift
|
Indirect | 2,445 Added 2.11% |
-
|
Mar 25
2014 |
|
FSLR
|
James Alton Hughes
Director |
SELL
Other acquisition or disposition
|
Direct | 2,817 Reduced 14.54% |
-
|
Mar 25
2014 |
|
JEF
|
Stuart Harry Reese |
BUY
Open market or private purchase
|
Direct | 4,000 Added 50.0% |
$108,440
$27.11 p/Share
|
Mar 25
2014 |
|
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 95.24% |
$3,827,000
$38.27 p/Share
|
Mar 25
2014 |
|
ORCL
|
Dorian Daley
EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 48.78% |
$2,104,000
$21.04 p/Share
|
Mar 25
2014 |
|
RAD
|
Castle Dedra Newman
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 65,184 Added 50.0% |
$425,000
$6.52 p/Share
|
Mar 24
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,140,035
$306.7 p/Share
|
Mar 24
2014 |
|
ADBE
|
John E Warnock
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 43.07% |
$1,486,500
$29.73 p/Share
|
Mar 24
2014 |